Physician profile
Cole Tunnell
NPI 1902240716
$1,814.77
in general payments reported to CMS, 2019-2025
16 companies · $597 in 2025
The $597 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.62 · 2020: $14.63 · 2021: $153 · 2023: $436 · 2024: $560 · 2025: $597.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,593.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,593.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $846.06 | 2023-2025 | |
| Philips North America LLC | $178.72 | 2024-2025 | (9520) Igt Devices Undivided, Extended Holter |
| Abiomed | $126.85 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $112.51 | 2019-2025 | Lifevest |
| Shockwave Medical, INC | $110.63 | 2025 | |
| Boston Scientific Corporation | $104.28 | 2023 | |
| Heartflow, INC. | $89.34 | 2023 | Ffrct |
| Amgen INC. | $64.12 | 2019-2025 | Repatha, Repatha |
| Inspire Medical Systems, INC. | $42.52 | 2024-2025 | Inspire |
| Chiesi USA, INC. | $28.89 | 2024 | Kengreal |
| Astrazeneca Pharmaceuticals LP | $26.63 | 2021 | |
| Sanofi-Aventis U.S. LLC | $20.11 | 2023 | |
| Kiniksa Pharmaceuticals, LTD. | $19.89 | 2023 | Arcalyst |
| E.R. Squibb & Sons, L.L.C. | $17.12 | 2025 | Camzyos |
| Janssen Pharmaceuticals, INC | $13.55 | 2023 | Xarelto |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $13.55 | 2025 | Hillrom - Carnation Ambulatory Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cole Tunnell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.